|
| 36373784 | Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition. | J Pathol | 2023 |
| 37804055 | Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma. | Liver Int | 2023 |
| 37349576 | The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer. | Commun Biol | 2023 |
| 37306553 | SIRIUS, Ultra-Scintillating Upconversion Breast Implant for Remote Orthotopic Photodynamic Therapy. | ACS Nano | 2023 |
| 37474650 | Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer. | Commun Biol | 2023 |
| 37032358 | Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma. | Mol Cancer | 2023 |
| 37463241 | Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma. | Cancer Res | 2023 |
| 36857629 | A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia. | Blood | 2023 |
| 36629283 | Immune-Hot tumor features associated with recurrence in early-stage ovarian clear cell carcinoma. | Int J Cancer | 2023 |
| 35163588 | The <i>H. pylori</i> CagA Oncoprotein Induces DNA Double Strand Breaks through Fanconi Anemia Pathway Downregulation and Replication Fork Collapse. | Int J Mol Sci | 2022 |
| 35731212 | TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling. | Mol Cancer Res | 2022 |
| 35503263 | BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. | J Clin Invest | 2022 |
| 35637517 | 3D genome organization in the epithelial-mesenchymal transition spectrum. | Genome Biol | 2022 |
| 35681502 | Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC). | Cells | 2022 |
| 35954433 | Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development. | Cancers (Basel) | 2022 |
| 35879421 | PI3Kδ activity controls plasticity and discriminates between EMT and stemness based on distinct TGFβ signaling. | Commun Biol | 2022 |
| 33478182 | Erratum: Iyer, A., et al. Integrative Analysis and Machine Learning Based Characterization of Single Circulating Tumor Cells. <i>J. Clin. Med.</i> 2020, <i>9</i>, 1206. | J Clin Med | 2021 |
| 33602783 | SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic <i>PTP4A3</i> through Chromatin Remodeling in t(4;14) Multiple Myeloma. | Cancer Res | 2021 |
| 33709473 | Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer. | EMBO Mol Med | 2021 |
| 33668151 | Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells. | Cancers (Basel) | 2021 |
| 33919917 | Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis. | Cancers (Basel) | 2021 |
| 33931443 | Topography of transcriptionally active chromatin in glioblastoma. | Sci Adv | 2021 |
| 33803139 | Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer. | Cancers (Basel) | 2021 |
| 34469741 | GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibility. | Cell Rep | 2021 |
| 34787118 | Evolution of CP2 transcription factors in Hexapoda. | J Genet | 2021 |
| 34580286 | Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers. | Cell Death Discov | 2021 |
| 34803496 | MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways. | Int J Biol Sci | 2021 |
| 34128838 | Doxycycline host-directed therapy in human pulmonary tuberculosis. | J Clin Invest | 2021 |
| 34322886 | A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma. | J Pathol | 2021 |
| 33391524 | Putting the BRK on breast cancer: From molecular target to therapeutics. | Theranostics | 2021 |
| 32370157 | SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. | Cancers (Basel) | 2020 |
| 31910334 | USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7. | EMBO Rep | 2020 |
| 31963677 | Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic Perspective. | Cancers (Basel) | 2020 |
| 32018052 | AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells. | J Thorac Oncol | 2020 |
| 31858684 | Response to: USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma. | EMBO Rep | 2020 |
| 31830480 | Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers. | Life Sci | 2020 |
| 33116254 | Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma. | Sci Rep | 2020 |
| 33334085 | Correction: Sundararajan, V., et al. SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. <i>Cancers</i> 2020, <i>12</i>, 1140. | Cancers (Basel) | 2020 |
| 33159134 | Author Correction: Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity. | Commun Biol | 2020 |
| 33103086 | AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer. | iScience | 2020 |
| 32973272 | OTUD4 enhances TGFβ signalling through regulation of the TGFβ receptor complex. | Sci Rep | 2020 |
| 32764731 | Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity. | Commun Biol | 2020 |
| 32900796 | Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer. | Clin Cancer Res | 2020 |
| 32895468 | Author Correction: Single-cell analysis of EphA clustering phenotypes to probe cancer cell heterogeneity. | Commun Biol | 2020 |
| 32667137 | Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. | EMBO Mol Med | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 32331451 | Integrative Analysis and Machine Learning based Characterization of Single Circulating Tumor Cells. | J Clin Med | 2020 |
| 32209656 | Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells. | J Biol Chem | 2020 |
| 32350249 | Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation. | Nat Commun | 2020 |
| 32560395 | Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique. | Cancers (Basel) | 2020 |